Latest Olanzapine Stories
Three-year data show olanzapine LAI safety findings consistent with oral olanzapine except for injection-related events INDIANAPOLIS, May 18 /PRNewswire-FirstCall/ -- Eli Lilly and Company presented today data on the short- and long-term efficacy and safety of olanzapine long-acting injection (LAI) in the treatment of adults with schizophrenia or schizoaffective disorder.
SAN DIEGO, March 29 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) announced today inconclusive Phase II clinical trial results from Study HBBI investigating LY2140023 monohydrate, also known as mGlu2/3, for the treatment of patients suffering from acute schizophrenia.
Antipsychotic drugs, such as olanzapine (Zyprexa), risperidone (Risperdal) and quetiapine (Seroquel), are commonly used to treat psychotic disorders like schizophrenia, but also bipolar disorder and even behavioral problems related to dementia.
New Indication is One of Three FDA Approvals Spanning Lilly Neuroscience Brands INDIANAPOLIS, March 23 /PRNewswire-FirstCall/ -- The U.S.
Indianapolis-based Eli Lilly & Co said Thursday that it had pleaded guilty to charges it had illegally marketed the anti-psychotic drug Zyprexa for off-label use, a misdemeanor violation of the Food, Drug and Cosmetic Act.
Philadelphia Attorney Stephen Sheller's Whistleblower Clients Help Government Recover $1.4 Billion Record Settlement and Criminal Fine in Eli Lilly & Company Zyprexa(R) Marketing Case Lead Attorney Filed Complaint in 2003 Representing Six Whistleblowers PHILADELPHIA, Jan.
$515 Million Criminal Fine is Largest Individual Corporate Criminal Fine in History; Civil Settlement Up To $800 Million WASHINGTON, Jan.
- A serpent whose bite was fabled to produce intense thirst.